DNA vs IMA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jan 27, 2026

DNA

62.5
AI Score
VS
IMA Wins

IMA

64.0
AI Score

Investment Advisor Scores

DNA

Jan 27, 2026
63score
Recommendation
BUY

IMA

Jan 27, 2026
64score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric DNA IMA Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -56.4% 0.0% IMA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 62.5/100 64.0/100 IMA
Profit Margin -188.0% 0.0% IMA
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation BUY BUY Tie

Frequently Asked Questions

Based on our detailed analysis, IMA is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.